Abstract
A 69-year-old female reported 2 weeks of bilateral blurred vision. She had metastatic ovarian carcinoma and had been enrolled in a randomized, controlled trial of niraparib and dostarlimab/placebo. This was paused for 11 days because of drug-induced hepatitis.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Canadian Journal of Ophthalmology/Journal canadien d'ophtalmologie
Paper Title
Journal
Date
